Based on the recent data of the DA VINCI study, it is clear that, besides utilization of statins, there is a need to increase non-statin lipid lowering approaches to reduce the cardiovascular burden in patients at highest risk.
Lipid Lowering Drugs: Present Status and Future Developments
Ferri, Nicola;
2021
Abstract
Based on the recent data of the DA VINCI study, it is clear that, besides utilization of statins, there is a need to increase non-statin lipid lowering approaches to reduce the cardiovascular burden in patients at highest risk.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Ruscica 2021 Curr Reviews in Atheroscl Lipid Lowering Drugs Present Statu.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Creative commons
Dimensione
674.68 kB
Formato
Adobe PDF
|
674.68 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
